HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yugendar R Alugubelli Selected Research

SARS-CoV-2 3C-like proteinase

1/2022MPI8 is Potent against SARS-CoV-2 by Inhibiting Dually and Selectively the SARS-CoV-2 Main Protease and the Host Cathepsin L.
12/2021The P3 O - Tert -Butyl-Threonine is Key to High Cellular and Antiviral Potency for Aldehyde-Based SARS-CoV-2 Main Protease Inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yugendar R Alugubelli Research Topics

Disease

8COVID-19
10/2022 - 07/2020

Drug/Important Bio-Agent (IBA)

4Antiviral Agents (Antivirals)IBA
10/2022 - 12/2021
3Peptide Hydrolases (Proteases)FDA Link
10/2022 - 07/2020
2N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
10/2022 - 12/2021
2Pharmaceutical PreparationsIBA
10/2022 - 12/2021
2EnzymesIBA
10/2022 - 12/2021
2SARS-CoV-2 3C-like proteinaseIBA
01/2022 - 12/2021
2Peptides (Polypeptides)IBA
01/2021 - 07/2020
2Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2020
1Cathepsin LIBA
01/2022